Juvéderm vs Restylane: the family-by-family comparison.

The single most common framing of this question — "Which is better, Juvéderm or Restylane?" — is also the least useful one. Both brands are families of hyaluronic-acid (HA) gels, and inside each family the individual products are engineered to behave very differently from one another. Asking which family is "better" is closer to asking whether Toyota or Honda is better: the answer depends entirely on which car, for which driver, on which road.

This guide treats them as families. Juvéderm is Allergan/AbbVie, built primarily on Vycross crosslinking technology. Restylane is Galderma, built on three distinct platforms (NASHA, OBT/XpresHAn, and a newer family of refinements including the chin-specific NASHA HD used in Shaype). We will walk through the maps, the rheology, the indication matches, the longevity ranges, and — most usefully — the typical first picks zone by zone.

The two families at a glance

Both families share the same backbone: cross-linked hyaluronic acid suspended in a buffered carrier, most current products with 0.3% lidocaine premixed for comfort. Both are reversible with hyaluronidase. Both have multi-year FDA histories. The differences live in how the HA chains are linked, how the resulting gel handles compression and shear, and how the manufacturer has segmented its product line.

Juvéderm (Allergan / AbbVie) — the Vycross family

Vycross is Allergan's proprietary crosslinking process that combines high-molecular-weight and low-molecular-weight HA chains in a single gel. The lower-weight chains pack more crosslinks into less HA, producing a gel that is often described as smoother, more cohesive, and longer-lasting than older Hylacross technology.

US-available Juvéderm products and their primary jobs:

• Juvéderm Voluma XC — high-G', high-lift filler for cheek augmentation and chin augmentation; also FDA-approved for moderate-to-severe temple hollowing.
• Juvéderm Volux XC — the firmest Vycross gel; FDA-approved for jawline improvement in adults over 21.
• Juvéderm Vollure XC — mid-firmness gel approved for moderate-to-severe nasolabial folds (NLFs) and similar mid-face wrinkles.
• Juvéderm Ultra Plus XC — robust gel approved for moderate-to-severe NLFs; also widely used off-label for lips when extra volume is desired.
• Juvéderm Ultra XC — softer gel approved for lip augmentation and perioral lines.
• Juvéderm Volbella XC — the softest, lowest-G' Vycross gel; approved for lip augmentation, perioral lines, and infraorbital (under-eye) hollows.
• Juvéderm Volift — available in EU/UK/other markets but not FDA-approved in the United States; commonly used for mid-face lines and lip definition abroad.

Restylane (Galderma) — three technology platforms

Galderma deliberately runs multiple platforms because no single crosslinking strategy is ideal for every tissue.

• NASHA (Non-Animal Stabilized Hyaluronic Acid) — minimal crosslinking (typically <1%), firm and particulate, designed to hold its shape and lift discrete structures.
• OBT / XpresHAn Technology — variable crosslinking density that produces a softer, more flexible gel intended to move with facial expression.
• NASHA HD — a newer, higher-density NASHA variant used in Shaype for chin projection.

US-available Restylane products (all premixed with 0.3% lidocaine unless noted):

• Restylane-L — the original NASHA gel; approved for moderate-to-severe facial wrinkles and lip augmentation.
• Restylane Lyft — firmer NASHA gel; FDA-approved for cheek augmentation, mid-face contour deficiencies, hands, and chin augmentation.
• Restylane Silk — fine, small-particle NASHA gel; approved for lip augmentation and perioral lines.
• Restylane Refyne — soft XpresHAn gel for mild-to-moderate NLFs and marionette lines; designed to flex with expression.
• Restylane Defyne — firmer XpresHAn gel for deeper NLFs and marionette lines; also FDA-approved for chin augmentation.
• Restylane Kysse — XpresHAn gel formulated specifically for lips; approved for lip augmentation and upper perioral lines.
• Restylane Contour — XpresHAn gel for cheek augmentation and midface contour; also approved for temple hollowing.
• Restylane Eyelight — NASHA-based, designed for the infraorbital hollow.
• Restylane Shaype — NASHA HD gel for chin augmentation; approved in Canada/EU and pending broader approval. In US clinics it appears only where it has cleared regulatory review.

The rheology you actually need to care about

Two numbers explain almost every "where should this go?" decision: G′ (G-prime, elastic modulus — the gel's resistance to deformation, i.e., its stiffness) and cohesivity (how well the gel holds together against shear and compression).

Practical translation:

• High G′, high cohesivity → behaves like bone. It resists collapse under skin tension. You want this on cheekbones, chin projection points, the jawline angle.
• Low G′, lower cohesivity → behaves like soft tissue. It integrates and moves. You want this in lips, tear troughs, and fine perioral lines, where a stiff gel would feel like a marble or visibly tent the skin.
• Mid-range G′ → the workhorse zone for nasolabial folds, marionette lines, and pre-jowl sulci, where the gel needs to hold a fold open but also bend with smiling.

Approximate G′ ranking within Juvéderm (high to low): Volux > Voluma > Vollure > Ultra Plus > Ultra > Volbella.

Approximate G′ ranking within Restylane (high to low): Shaype > Lyft > Restylane-L / Eyelight > Defyne > Contour > Kysse > Refyne > Silk.

(Exact G′ values vary by lab and methodology; the rank-order is what matters at the chairside.)

One useful pattern: NASHA products (Lyft, Restylane-L, Silk, Eyelight, Shaype) tend to be firmer and more particulate than their G′ alone suggests, because the low crosslinking percentage leaves discrete HA particles in suspension rather than a continuous gel. They lift well on bone but can feel firmer to palpation in soft tissue. XpresHAn products (Refyne, Defyne, Kysse, Contour) are monophasic and stretchier, which is why Galderma markets them for expressive zones.

Vycross gels (the Vol- line) sit somewhere different again: they are highly cohesive monophasic gels that combine relatively high G′ with high spreadability — which is why Voluma can both project a cheekbone and feather out smoothly under thin skin.

Indication match: where each one belongs

This is the table that does most of the work in a real consultation. "Typical first pick" assumes the indication is on-label or well-established off-label, the patient has no specific contraindication, and the injector is comfortable with both families.

A note on the tear trough: this is the single zone where product choice matters most, because the skin is thin, the lighting is unforgiving, and HA is hydrophilic. Volbella and the NASHA-based Restylane Eyelight are both formulated specifically to minimize water uptake in this region. Voluma and Lyft are not first-line tear-trough fillers, even though many experienced injectors do use small, deep, supraperiosteal aliquots of either for orbital rim work.

Longevity ranges

Manufacturer claims and the peer-reviewed literature roughly agree on these envelopes. Real-world duration varies with metabolism, muscle activity in the treated zone, depth of placement, and total volume.

The pattern: Vycross gels tend to outlast comparable NASHA/XpresHAn products by a few months in the same anatomic zone, particularly for deep-tissue volumizers like Voluma vs Lyft. This is consistent with their higher crosslink density and slower enzymatic degradation, which is also why Voluma takes more hyaluronidase to dissolve than Restylane-L gram-for-gram.

Lidocaine, reversibility, and the practical bits

Almost every product in current US use is the "XC" or "-L" version, meaning 0.3% lidocaine is premixed into the gel. This matters for comfort but also means patients with documented amide-anesthetic allergy need the rare lidocaine-free formulation or a different approach entirely.

Both families are dissolvable with hyaluronidase, but not equally easily. Side-by-side in-vitro studies consistently show that Restylane-L and other NASHA gels begin to degrade at lower hyaluronidase doses than Vycross gels, particularly Voluma, which can require substantially more enzyme to fully dissolve. In practical terms: a vascular complication or a misplaced bolus is treatable in either family, but resolving a chronic Voluma nodule may take more sessions of hyaluronidase than resolving a Lyft nodule of similar volume.

Cohesivity also affects what "dissolving" looks like in tissue. Monophasic Vycross gels tend to break down as a connected mass; NASHA particles tend to disperse and clear more diffusely. Neither is universally better — it changes how the injector approaches the dissolution.

How a typical full-face stack looks in clinical practice

Most experienced injectors are bilingual across the two families, and a single patient often ends up with products from both. Two representative patterns:

The structural patient — flatter midface, weak chin, soft jawline.

• Cheeks: Voluma XC or Lyft, supraperiosteal, lateral and medial cheek pillars.
• Chin: Volux XC or Defyne, supraperiosteal at the pogonion and mentum.
• Jawline: Volux XC or Lyft along the mandibular border and pre-jowl sulcus.
• Tear trough: Volbella XC or Eyelight, deep on the orbital rim, only after midface is supported.

The expressive patient — moderate folds, dynamic perioral motion, lip-forward goals.

• NLFs and marionettes: Vollure XC or Defyne, mid-deep dermis.
• Lips: Kysse or Volbella XC, depending on whether the goal is plump-with-shape (Kysse) or definition-and-hydration (Volbella).
• Perioral lines: Volbella XC or Silk, fine cannula or microdroplet technique.

The pattern that isn't clinically defensible is "I only use Juvéderm" or "I only use Restylane." Each family has clear strengths, and the cost of brand loyalty is paid by the patient in suboptimal product-to-zone match.

How to choose if you're the patient

A short decision tree that mirrors how most thoughtful injectors actually think:

1. What zone are we treating? Start there, not with the brand. The zone narrows the rheology you want.
2. How expressive is the zone? Lips, lower face, and marionettes benefit from stretchier gels (XpresHAn or low-G′ Vycross). Bone-anchored zones (zygoma, mandibular angle, chin point) benefit from firm gels (NASHA Lyft/Shaype or high-G′ Vycross like Voluma/Volux).
3. What's the longevity target? If you want maximum duration in a stable zone (e.g., cheekbones for two years), Vycross has a small edge. If you want to "try" a treatment and reassess in a year, NASHA/XpresHAn is forgiving.
4. Have you had filler before, and where is it? Existing filler influences both product choice and depth. Layering Vycross on Vycross is straightforward; switching families mid-treatment is fine but the injector should know what's already in the tissue.
5. Is the injector fluent in both families? This is the single biggest predictor of result quality — bigger than the brand choice itself.

If you remember one sentence from this article, make it this: the brand is not the variable. The product, the zone, the depth, and the injector are the variables. Juvéderm and Restylane are toolboxes, and a good treatment plan opens both.

Sources

• FDA AccessData, Premarket Approval (PMA) database — Juvéderm products (P050047 and supplements): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050047
• FDA AccessData, Summary of Safety and Effectiveness Data, Restylane Injectable Gel (P020023): https://www.accessdata.fda.gov/cdrh_docs/pdf2/P020023b.pdf
• FDA AccessData, Premarket Approval database — Restylane family (P040024 and supplements): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P040024
• FDA, Dermal Fillers Approved by the Center for Devices and Radiological Health: https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-approved-center-devices-and-radiological-health
• American Society for Dermatologic Surgery, "Soft Tissue Fillers Guide": https://www.asds.net/skin-experts/skin-treatments/soft-tissue-fillers
• American Academy of Dermatology, "Fillers: Overview": https://www.aad.org/public/cosmetic/younger-looking/fillers-overview
• American Society of Plastic Surgeons, "Dermal Fillers": https://www.plasticsurgery.org/cosmetic-procedures/dermal-fillers
• Allergan/AbbVie, Juvéderm Collection product information: https://www.juvederm.com/
• Galderma, Restylane Science & Technology (NASHA and XpresHAn platforms): https://www.restylaneusa.com/restylane-science
• Galderma news release, Restylane Shaype regulatory approval: https://www.galderma.com/news/galderma-announces-regulatory-approval-restylaner-shaypetm-new-hyaluronic-acid-injectable
• Sundaram H, et al., "Comparison of the Rheological Properties of Viscosity and Elasticity in Two Categories of Soft Tissue Fillers" (PubMed): https://pubmed.ncbi.nlm.nih.gov/22273750/
• Rao V, et al., "Reversing Facial Fillers: Interactions Between Hyaluronidase and Commercially Available Hyaluronic-Acid Based Fillers" (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC4570078/
• Juhasz MLW, Levin MK, "The Use of Hyaluronidase in Aesthetic Practice" — review (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC5868779/
• Rauso R, et al., "Choosing Juvéderm Volux for chin augmentation: case report and flowchart" (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC10800642/
• Goodman GJ, et al., "Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion" (PubMed, Shaype pivotal trial): https://pubmed.ncbi.nlm.nih.gov/38564392/